Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598585 · ClinicalTrials.gov registry record · Phase 4
Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
A Phase 4 study, sponsored by Charles Drew University of Medicine and Science.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00598585 is a Phase 4 study that has completed, run by Charles Drew University of Medicine and Science. The registered enrollment target is 12 participants.
The verdict
NCT00598585, a Phase 4 study, has completed, sponsored by Charles Drew University of Medicine and Science.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
Use of Viagra to Alter Symptoms in Patients with Chronic Fatigue Syndrome (CFS)
Interventions
- DRUG Placebo
- DRUG Sildenafil (Viagra)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2002-07 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00598585
The ClinicalTrials.gov registry entry for NCT00598585 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Charles Drew University of Medicine and Science, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00598585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00598585 about?
NCT00598585 is a clinical study titled "Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS". Use of Viagra to Alter Symptoms in Patients with Chronic Fatigue Syndrome (CFS)
What is the current status of trial NCT00598585?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2002-07. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00598585?
The interventions under investigation include: Placebo (DRUG), Sildenafil (Viagra) (DRUG).
Who is sponsoring clinical trial NCT00598585?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.